Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

COVID-19: vaccination problems.

Environmental microbiology - 1 Jun 2021

Brüssow Harald

Abstract excerpt

This minireview addresses problems of financing the vaccine development, regulatory questions, the ethics and efficacy of vaccine prioritization strategies and the coverage of variant viruses by current vaccines. Serious adverse effects observed with adenovirus vectored vaccines and mRNA vaccines in mass vaccination campaigns are reported. The ethical problems of continuing with placebo controlled vaccine trials...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Trials as Topic
Share to COVID-19
Share to COVID-19 Vaccines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Development

Share to Genetic Variation

Share to SARS-CoV-2

Share to Vaccination

Source

Open in PubMed Open full text

Identifiers

PMID: 33928745
DOI: 10.1111/1462-2920.15549
PMCID: PMC8209888

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

COVID-19: vaccination problems.PMID 33928745Read ↗

Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and SafetySemantic proximity Read ↗

COVID-19 vaccines: breaking record times to first-in-human trialsSemantic proximity Read ↗

Pros and Cons of Adenovirus-Based SARS-CoV-2 VaccinesSemantic proximity Read ↗

Vaccines based on the replication-deficient simian adenoviral vector ChAdOx1: Standardized template with key considerations for a risk/benefit assessmentSemantic proximity Read ↗

New Insights on Adenovirus as Vaccine VectorsSemantic proximity Read ↗

Immunogenicity and safety of a recombinant adenovirus type-5 COVID-19 vaccine in adults: data from a randomised, double-blind, placebo-controlled, single-dose, phase 3 trial in RussiaSemantic proximity Read ↗

COVID-19 Vaccines Based on Adenovirus VectorsSemantic proximity Read ↗

A Re-Analysis of EU’s COVID-19 Vaccine Procurement Strategy in View of the An-Ticipated Cost-effectiveness of VaccinationSemantic proximity Read ↗

Dose of approved COVID-19 vaccines is based on weak evidence: a review of early-phase, dose-finding trialsSemantic proximity Read ↗

Vaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerations for a risk/benefit assessmentSemantic proximity Read ↗

SARS CoV-2 adenovirus and RNA based vaccines potential autoimmune complications: could we lower the chances?Semantic proximity Read ↗

Necessity of 2 Doses of the Pfizer and Moderna COVID-19 Vaccines.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.